435 related articles for article (PubMed ID: 16955493)
1. Exposure to 5-bromo-2'-deoxyuridine induces oxidative stress and activator protein-1 DNA binding activity in the embryo.
Sahambi SK; Hales BF
Birth Defects Res A Clin Mol Teratol; 2006 Aug; 76(8):580-91. PubMed ID: 16955493
[TBL] [Abstract][Full Text] [Related]
2. The oxidative stress response is region specific in organogenesis stage mouse embryos exposed to 5-bromo-2'-deoxyuridine.
Gnanabakthan N; Hales BF
Birth Defects Res A Clin Mol Teratol; 2009 Mar; 85(3):202-10. PubMed ID: 19161159
[TBL] [Abstract][Full Text] [Related]
3. Activator protein-1 (AP-1) DNA binding activity is induced by hydroxyurea in organogenesis stage mouse embryos.
Yan J; Hales BF
Toxicol Sci; 2005 Jun; 85(2):1013-23. PubMed ID: 15772364
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress regulates the expression and activity of transcription factor activator protein-1 in rat conceptus.
Ozolins TR; Hales BF
J Pharmacol Exp Ther; 1997 Feb; 280(2):1085-93. PubMed ID: 9023327
[TBL] [Abstract][Full Text] [Related]
5. Buthionine sulfoximine embryotoxicity is associated with prolonged AP-1 activation.
Ozolins TR; Harrouk W; Doerksen T; Trasler JM; Hales BF
Teratology; 2002 Oct; 66(4):192-200. PubMed ID: 12353216
[TBL] [Abstract][Full Text] [Related]
6. Depletion of glutathione induces 4-hydroxynonenal protein adducts and hydroxyurea teratogenicity in the organogenesis stage mouse embryo.
Yan J; Hales BF
J Pharmacol Exp Ther; 2006 Nov; 319(2):613-21. PubMed ID: 16902051
[TBL] [Abstract][Full Text] [Related]
7. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
[TBL] [Abstract][Full Text] [Related]
8. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Miranda AF; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific regulation of glutathione homeostasis and the activator protein-1 (AP-1) response in the rat conceptus.
Ozolins TR; Hales BF
Biochem Pharmacol; 1999 May; 57(10):1165-75. PubMed ID: 11230805
[TBL] [Abstract][Full Text] [Related]
10. Glutathione oxidation and embryotoxicity elicited by diamide in the developing rat conceptus in vitro.
Hiranruengchok R; Harris C
Toxicol Appl Pharmacol; 1993 May; 120(1):62-71. PubMed ID: 8511783
[TBL] [Abstract][Full Text] [Related]
11. The role of maternal toxicity in lovastatin-induced developmental toxicity.
Lankas GR; Cukierski MA; Wise LD
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
[TBL] [Abstract][Full Text] [Related]
12. A role for glutathione, independent of oxidative stress, in the developmental toxicity of methanol.
Siu MT; Shapiro AM; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):508-15. PubMed ID: 24095963
[TBL] [Abstract][Full Text] [Related]
13. Chloroacetonitrile induces oxidative stress and apoptosis in mouse fetal liver.
Abdel-Naim AB; Nagy AA; Mohamadin AM; El-Mazar HM; Ahmed AE
Toxicol Lett; 2009 Oct; 190(2):123-7. PubMed ID: 19576970
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress status and development of late organogenesis stage rat whole embryos cultured from gestational days 13.5 to 14.5.
Liu JN; Chan HM; Kubow S
Toxicol In Vitro; 2007 Feb; 21(1):53-62. PubMed ID: 17056224
[TBL] [Abstract][Full Text] [Related]
15. Increased activator protein 1 activity as well as resistance to heat-induced radiosensitization, hydrogen peroxide, and cisplatin are inhibited by indomethacin in oxidative stress-resistant cells.
Bradbury CM; Locke JE; Wei SJ; Rene LM; Karimpour S; Hunt C; Spitz DR; Gius D
Cancer Res; 2001 Apr; 61(8):3486-92. PubMed ID: 11309312
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
17. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro.
Chen B; Cyr DG; Hales BF
Teratology; 1994 Jul; 50(1):1-12. PubMed ID: 7974249
[TBL] [Abstract][Full Text] [Related]
18. Anomalous neural differentiation induced by 5-bromo-2'-deoxyuridine during organogenesis in the rat.
Biggers WJ; Barnea ER; Sanyal MK
Teratology; 1987 Feb; 35(1):63-75. PubMed ID: 3563938
[TBL] [Abstract][Full Text] [Related]
19. Real time microfiberoptic redox fluorometry: modulation of the pyridine nucleotide status of the organogenesis-stage rat visceral yolk sac with cyanide and alloxan.
Thorsrud BA; Harris C
Toxicol Appl Pharmacol; 1995 Dec; 135(2):237-45. PubMed ID: 8545833
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of early embryonic neurogenesis after exposure to the genotoxic agent 5-bromo-2'-deoxyuridine in mice.
Kuwagata M; Ogawa T; Nagata T; Shioda S
Neurotoxicology; 2007 Jul; 28(4):780-9. PubMed ID: 16956662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
